Cited by 84Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryRetinal Diseases and Treatments

Antiangiogenic nanomicelles for the topical delivery of aflibercept to treat retinal neovascular disease

Zhao, Xinxin, Seah, Ivan, Xue, Kun, Wong, Wendy, Tan, Queenie Shu Woon, Ma, Xiaoxiao, Lin, Qianyu, Lim, Jason Y. C. +11 more·2022·Advanced Materials

Abstract

The traditional intravitreal injection delivery of antivascular endothelial growth factor (anti-VEGF) to the posterior segment of the eye for treatment of retinal diseases is invasive and associated with sight-threatening complications. To avoid such complications, there has been significant interest in developing polymers for topical drug delivery to the retina. This study reports a nanomicelle drug delivery system made of a copolymer EPC (nEPCs), which is capable of delivering aflibercept to the posterior segment topically through corneal-scleral routes. EPC is composed of poly(ethylene glycol) (PEG), poly(propylene glycol) (PPG), and polycaprolactone (PCL) segments. In this study, aflibercept-loaded nEPCs (nEPCs + A) are capable of penetrating the cornea in ex vivo porcine eye models and deliver a clinically significant amount of aflibercept to the retina in laser-induced choroidal neovascularization (CNV) murine models, causing CNV regression. nEPCs + A also demonstrate biocompatibility in vitro and in vivo. Interestingly, this study also suggests that nEPCs have intrinsic antiangiogenic properties. The ability to deliver anti-VEGF drugs and the intrinsic antiangiogenic properties of nEPCs may result in synergistic effects, which can be harnessed for effective therapeutics. nEPCs may be a promising topical anti-VEGF delivery platform for the treatment of retinal diseases.

Integrity signals

Registry

Crossref · 10.1002/adma.202108360

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Aflibercept-loaded nEPCs were capable of penetrating the cornea in ex vivo porcine eye models, and delivered clinically effective quantities of aflibercept to the retina in laser-induced CNV murine models.

    “Researchers demonstrated that aflibercept-loaded nEPCs were capable of penetrating the cornea in ex vivo porcine eye models, and delivered a clinically effective quantities of aflibercept to the retina in the laser-induced CNV murine models.”
  • nEPCs possess intrinsic antiangiogenic properties, which may yield synergistic outcomes in conjunction with their dual capacity to deliver anti-VEGF therapeutics.

    “Notably, this research also demonstrates that nEPCs possess intrinsic antiangiogenic properties, which may yield synergistic outcomes in conjunction with their dual capacity to deliver anti-VEGF therapeutics, thereby offering a promising remedy [193].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhao, X., Seah, I., Xue, K., Wong, W., Tan, Q. S. W., Ma, X., Lin, Q., Lim, J. Y. C., Liu, Z., Parikh, B. H., Mehta, K. N., Lai, J. W., Yang, B., Tran, K. C., Barathi, V. A., Cheong, K. H., Hunziker, W., Su, X., & Loh, X. J.
Affiliations
  • Agency for Science, Technology and Research (SG)
  • National University Hospital (SG)
  • Singapore University of Technology and Design (SG)
  • National University of Singapore (SG)
Corresponding author
  • Su, Xinyi
  • Loh, Xian Jun
Venue
Advanced Materials
Publisher
Wiley
Published
2021-12-02
Volume
34
Issue
25
Pages
e2108360-e2108360
ISSN
  • 0935-9648 (ISSN-L)
  • 1521-4095
OpenAlex
W3208137158
Cited by
84
References
48
Citations by year
2026: 5 · 2025: 24 · 2024: 24 · 2023: 18 · 2022: 12 · 2021: 1
FWCI
5.55
Type
journal article
Language
en
Open access
closed
Locations
  • Advanced Materials (publishedVersion)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion)
Funders
Agency for Science, Technology and Research (H17/01/a0/013)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
nanomicelles, aflibercept, topical drug delivery, retinal neovascular disease, choroidal neovascularization, anti-VEGF therapy, corneal penetration, polycaprolactone, polyethylene glycol, polypropylene glycol, intravitreal injection alternatives, porcine eye model, biocompatibility
MeSH terms
Animals, Recombinant Fusion Proteins, Retinal Diseases, Swine, Drug Delivery Systems, Choroidal Neovascularization, Angiogenesis Inhibitors, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor A, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review